The histone demethylase JARID1A is associated with susceptibility to ankylosing spondylitis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The histone demethylase JARID1A is associated with susceptibility to ankylosing spondylitis. / Pointon, J. J.; Harvey, D.; Karaderi, T.; Appleton, L. H.; Farrar, C.; Wordsworth, B. P.

I: Genes and Immunity, Bind 12, Nr. 5, 01.07.2011, s. 395-398.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Pointon, JJ, Harvey, D, Karaderi, T, Appleton, LH, Farrar, C & Wordsworth, BP 2011, 'The histone demethylase JARID1A is associated with susceptibility to ankylosing spondylitis', Genes and Immunity, bind 12, nr. 5, s. 395-398. https://doi.org/10.1038/gene.2011.23

APA

Pointon, J. J., Harvey, D., Karaderi, T., Appleton, L. H., Farrar, C., & Wordsworth, B. P. (2011). The histone demethylase JARID1A is associated with susceptibility to ankylosing spondylitis. Genes and Immunity, 12(5), 395-398. https://doi.org/10.1038/gene.2011.23

Vancouver

Pointon JJ, Harvey D, Karaderi T, Appleton LH, Farrar C, Wordsworth BP. The histone demethylase JARID1A is associated with susceptibility to ankylosing spondylitis. Genes and Immunity. 2011 jul. 1;12(5):395-398. https://doi.org/10.1038/gene.2011.23

Author

Pointon, J. J. ; Harvey, D. ; Karaderi, T. ; Appleton, L. H. ; Farrar, C. ; Wordsworth, B. P. / The histone demethylase JARID1A is associated with susceptibility to ankylosing spondylitis. I: Genes and Immunity. 2011 ; Bind 12, Nr. 5. s. 395-398.

Bibtex

@article{6dd057097c0d4259812ea9da8122bd66,
title = "The histone demethylase JARID1A is associated with susceptibility to ankylosing spondylitis",
abstract = "Associations with disease identified by genome-wide association studies (GWAS) must be replicated and refined to validate causative variants. In the Wellcome Trust Case Control Consortium (WTCCC) GWAS using 14 500 non-synonymous single nucleotide polymorphisms (nsSNP), rs11062385 (a nsSNP in JARID1A) showed nominal association with ankylosing spondylitis (AS) (P=0.0006, odds ratio (OR)=1.26, 95% confidence interval (95% CI)=1.1-1.4). To replicate and refine the association of JARID1A, rs11062385 was genotyped in 730 further cases and compared with allele frequencies in non-AS disease cohorts typed by WTCCC. We replicated the initial association (P=0.04, OR=1.16, 95% CI=1.01-1.34) and identified a strengthened association with AS in a meta-analysis of this new study combined with the original WTCCC study (P=0.0001, OR=1.21, 95% CI=1.10-1.33). We also genotyped nine further intronic tagging SNPs in JARID1A in 1604 AS cases and 1020 new control samples, but none was associated with AS. JARID1A or a locus in strong linkage disequilibrium with it is a positional candidate for susceptibility to AS.",
keywords = "genome-wide association study, JARID1A, meta-analysis, Spondyloarthropathy",
author = "Pointon, {J. J.} and D. Harvey and T. Karaderi and Appleton, {L. H.} and C. Farrar and Wordsworth, {B. P.}",
year = "2011",
month = jul,
day = "1",
doi = "10.1038/gene.2011.23",
language = "English",
volume = "12",
pages = "395--398",
journal = "Genes and Immunity",
issn = "1466-4879",
publisher = "nature publishing group",
number = "5",

}

RIS

TY - JOUR

T1 - The histone demethylase JARID1A is associated with susceptibility to ankylosing spondylitis

AU - Pointon, J. J.

AU - Harvey, D.

AU - Karaderi, T.

AU - Appleton, L. H.

AU - Farrar, C.

AU - Wordsworth, B. P.

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Associations with disease identified by genome-wide association studies (GWAS) must be replicated and refined to validate causative variants. In the Wellcome Trust Case Control Consortium (WTCCC) GWAS using 14 500 non-synonymous single nucleotide polymorphisms (nsSNP), rs11062385 (a nsSNP in JARID1A) showed nominal association with ankylosing spondylitis (AS) (P=0.0006, odds ratio (OR)=1.26, 95% confidence interval (95% CI)=1.1-1.4). To replicate and refine the association of JARID1A, rs11062385 was genotyped in 730 further cases and compared with allele frequencies in non-AS disease cohorts typed by WTCCC. We replicated the initial association (P=0.04, OR=1.16, 95% CI=1.01-1.34) and identified a strengthened association with AS in a meta-analysis of this new study combined with the original WTCCC study (P=0.0001, OR=1.21, 95% CI=1.10-1.33). We also genotyped nine further intronic tagging SNPs in JARID1A in 1604 AS cases and 1020 new control samples, but none was associated with AS. JARID1A or a locus in strong linkage disequilibrium with it is a positional candidate for susceptibility to AS.

AB - Associations with disease identified by genome-wide association studies (GWAS) must be replicated and refined to validate causative variants. In the Wellcome Trust Case Control Consortium (WTCCC) GWAS using 14 500 non-synonymous single nucleotide polymorphisms (nsSNP), rs11062385 (a nsSNP in JARID1A) showed nominal association with ankylosing spondylitis (AS) (P=0.0006, odds ratio (OR)=1.26, 95% confidence interval (95% CI)=1.1-1.4). To replicate and refine the association of JARID1A, rs11062385 was genotyped in 730 further cases and compared with allele frequencies in non-AS disease cohorts typed by WTCCC. We replicated the initial association (P=0.04, OR=1.16, 95% CI=1.01-1.34) and identified a strengthened association with AS in a meta-analysis of this new study combined with the original WTCCC study (P=0.0001, OR=1.21, 95% CI=1.10-1.33). We also genotyped nine further intronic tagging SNPs in JARID1A in 1604 AS cases and 1020 new control samples, but none was associated with AS. JARID1A or a locus in strong linkage disequilibrium with it is a positional candidate for susceptibility to AS.

KW - genome-wide association study

KW - JARID1A

KW - meta-analysis

KW - Spondyloarthropathy

UR - http://www.scopus.com/inward/record.url?scp=79960630577&partnerID=8YFLogxK

U2 - 10.1038/gene.2011.23

DO - 10.1038/gene.2011.23

M3 - Journal article

C2 - 21562575

AN - SCOPUS:79960630577

VL - 12

SP - 395

EP - 398

JO - Genes and Immunity

JF - Genes and Immunity

SN - 1466-4879

IS - 5

ER -

ID: 226396946